PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Primary Health Care Service Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.\', \'Unitat de Suport a la Recerca Tarragona-Reus, IDIAP Jordi Gol, Barcelona, Spain.\', \'Department of Information and Communication Technologies, DAP Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.\', \'Department of Microbiology, Hospital Universitari Joan XXIII, Institut Catala de la Salut, Tarragona, Spain.\', \'Department of Farmacology, DAP Camp de Tarragona, Institut Catala de la Salut, Tarragona, Spain.\', \'Department of Laboral Medicine, ACTIVA Mutua, Tarragona, Spain.\', \'Fundació Institut Universitari per a la recerca a l\'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jch.13948
?:hasPublicationType
?:journal
  • Journal of clinical hypertension (Greenwich, Conn.)
is ?:pmid of
?:pmid
?:pmid
  • 32710674
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: A population-based cohort study in Southern Catalonia, Spain.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all